能分辨癌细胞和正常细胞并将癌细胞杀死的单克隆抗体已应用于临床。目前,东京大学医学部第三内科高久史磨教授正在开发的小细胞肺癌的单克隆抗体和帝国人造公司以实用化为目标,治疗白血病用的单克隆抗体和黑色素瘤的单克隆抗体都属于这种抗体。单克隆抗体是仅杀死癌细胞的导弹治疗 Monoclonal antibodies that recognize and kill cancer cells and normal cells have been used clinically. Currently, monoclonal antibodies to small cell lung cancer developed by the professor of medical sciences at the Third Faculty of Medicine of the University of Tokyo, and Imperial Man-Made Company have been put into practical use for their practical application. Monoclonal antibodies against leukemias and monoclonal antibodies against melanoma belong to this category antibody. Monoclonal antibodies are missile treatments that kill only cancer cells